{"database": "lobbying", "table": "lobbying_activities", "rows": [[3005353, "b43874d0-d12e-4a29-90a9-66dd0a10e299", "Q2", "FORBES-TATE", 400976792, "LYKOS THERAPEUTICS", 2023, "second_quarter", "VET", "Issues related to alternative treatments for PTSD and research in treating behavioral health challenges.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2023-07-15T19:00:17-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3005353"], "units": {}, "query_ms": 98.4035519650206, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}